Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Infectious Diseases Drugs 244
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 174
Immune Disorders Drugs 154
Women's Health 134
Central Nervous System Drugs 133
Animal Pharmaceuticals 132
Cardiovascular Drugs 124
Pharmaceuticals 112
Musculoskeletal Disorders Drugs 102
Drug Discovery 97
Biopharmaceuticals 92
Respiratory Drugs 81
Clinical Trials 74
Oncology 74
Allergy and Immunology 72
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 61
Biotechnology 60
Drug Delivery 60
Gastrointestinal Drugs 60
Enzymes 57
Genomics 49
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 37
Diagnostics 36
Pulmonary Medicine 35
Lymphoma Drugs 35
Cancer Vaccines 33
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Pharmaceutical Intermediates 31
Lung Cancer Drugs 29
Urological Disorders Drugs 29
Optical 28
Pharmaceutical Manufacturing 28
HIV/AIDS Drugs 27
Liver Cancer Drugs 26
Over the Counter (OTC) Drugs 26
Healthcare Services 24
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Cardiology 21
Leukemia Drugs 20
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
Vitamins and Dietary Supplements 16
Bladder Cancer Drugs 15
Biomarkers 15
E-Healthcare 14
Medical Devices 14
Hematology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Gastroenterology 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Transdermal and Transmucosal Drug Delivery 10
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Bronchitis Drugs 7
Healthcare 6
Needles and Syringes 6
Uterine Cancer Drugs 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Proteomics 5
Hepatology 4
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Wound Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

3,364 Results (Page 59 of 169)
- Relevance
  Sort by

Nasopharyngeal Cancer Treatment Market - Global Strategic Business Report

 Report
February 2026
288 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Personalized Cancer Medicines Market - Global Strategic Business Report

 Report
February 2026
267 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Immunotherapy Drugs - Global Strategic Business Report

 Report
February 2026
193 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Immune Checkpoint Inhibitors - Global Strategic Business Report

 Report
February 2026
194 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Myeloproliferative Neoplasms Treatment Market - Global Strategic Business Report

 Report
February 2026
368 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

$Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report

 Report
February 2026
287 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Angiosarcoma Treatment Market - Global Strategic Business Report

 Report
February 2026
390 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Hedgehog Pathway Inhibitors Market - Global Strategic Business Report

 Report
February 2026
102 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Ewing Sarcoma Market - Global Strategic Business Report

 Report
February 2026
377 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Cytotoxic Drugs - Global Strategic Business Report

 Report
February 2026
462 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Tumor Necrosis Factor Inhibitor Drugs Market - Global Strategic Business Report

 Report
February 2026
291 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Retinoblastoma Treatment Market - Global Strategic Business Report

 Report
February 2026
279 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Stomach Cancer Treatment Market - Global Strategic Business Report

 Report
February 2026
371 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Oropharyngeal Cancer Diagnosis and Therapeutics Market - Global Strategic Business Report

 Report
February 2026
395 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Adrenocortical Carcinoma Treatment - Global Strategic Business Report

 Report
February 2026
289 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Oral Cancer Treatment - Global Strategic Business Report

 Report
February 2026
279 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

 Report
February 2026
171 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Metastatic Bone Disease - Global Strategic Business Report

 Report
February 2026
194 Pages
Global

From

€5103EUR$5,850USD£4,447GBP

Biopharmaceutical Fermentation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
110 Pages
Global

From

€4143EUR$4,750USD£3,611GBP

Companion Animal Healthcare Market 2024-2028

 Report
August 2024
137 Pages
Global

From

€2181EUR$2,500USD£1,900GBP

3,364 Results (Page 59 of 169)
- 1
- 57
- 58
- 59
- 60
- 61

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.